![]() ![]() INTRODUCTION Topical aerosol products contain the drug in solution or in suspension, packaged under pressure, and released upon activation of an appropriate valve system. The topical aerosol products should follow the product quality test requirements described in general test chapters Inhalation and Nasal Drug Products—General Information and Product Quality Tests
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() DELIVERY RATE AND DELIVERED AMOUNT Perform these tests only on containers fitted with continuous valves.
Delivery Rate:
Select NLT four aerosol containers; shake, if the label includes this directive; remove the caps and covers; and actuate each valve for 2–3 s. Weigh each container accurately, and immerse in a constant-temperature bath until the internal pressure is equilibrated at a temperature of 25
![]()
Delivered Amount:
Return the containers to the constant-temperature bath, continuing to deliver 5 s actuations to waste, until each container is exhausted. [Note—Ensure that sufficient time is allowed between each actuation to avoid significant canister cooling. ] Calculate the total weight loss from each container. This is the Delivered Amount.
PRESSURE TEST Perform this test only on topical aerosols fitted with continuous valves.
Select NLT four aerosol containers, remove the caps and covers, and immerse in a constant-temperature bath until the internal pressure is constant at a temperature of 25
![]() MINIMUM FILL Topical aerosols meet the requirements for aerosols in Minimum Fill
![]() ![]() LEAKAGE TEST Proceed as directed in Leak Rate
![]() ![]() NUMBER OF DISCHARGES PER CONTAINER Perform this test only on topical aerosols fitted with dose-metering valves, at the same time as, and on the same containers used for, the test for Delivered-Dose Uniformity. Determine the number of discharges or deliveries by counting the number of priming discharges plus those used in determining the spray contents, and continue to fire until the label claim number of discharges. The requirements are met if all the containers or inhalers tested contain NLT the number of discharges stated on the label.
DELIVERED-DOSE UNIFORMITY The test for Delivered-Dose Uniformity is required for topical aerosols fitted with dose-metering valves. For collection of the minimum dose, proceed as directed in the test for Delivered Dose Uniformity in Metered-Dose Inhalers and Dry Powder Inhalers, as described in
![]() ![]() ![]() ![]()
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
USP38–NF33 Page 415
Pharmacopeial Forum: Volume No. 39(1)
|